Consistent with this hypothesis, an LMP-promoting role of STAT3 has been documented in several previous studies, for example during mammary gland involution [33,34] as well as in breast cancer cells treated with a derivative of the natural molecule riccardin D [35]. Here, STAT3 is linked to breast carcinoma.